Ginkgo Bioworks Holdings Shares Outstanding 2020-2022 | DNA

Ginkgo Bioworks Holdings shares outstanding from 2020 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Ginkgo Bioworks Holdings Annual Shares Outstanding
(Millions of Shares)
2021 1,360
2020 1,275
2019 1,149
Ginkgo Bioworks Holdings Quarterly Shares Outstanding
(Millions of Shares)
2022-03-31 1,608
2021-12-31 1,360
2021-09-30 1,324
2021-06-30 43
2021-03-31 1,290
2020-12-31
2020-09-30 1,287
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.637B $0.314B
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $167.557B 10.19
Bio-Rad Laboratories (BIO.B) United States $14.121B 30.63
QIAGEN (QGEN) Netherlands $10.634B 16.78
Biohaven Pharmaceutical Holding (BHVN) United States $10.186B 0.00
Arcus Biosciences (RCUS) United States $1.751B 44.40
Emergent Biosolutions (EBS) United States $1.570B 6.72
Myovant Sciences (MYOV) United Kingdom $1.212B 0.00
Zymeworks (ZYME) Canada $0.325B 0.00
Gelesis Holdings (GLS) United States $0.111B 0.00
Ambrx Biopharma (AMAM) United States $0.102B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
SQZ Biotechnologies (SQZ) United States $0.091B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00